Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention
The University of Texas Health Science Center, Houston · with National Institutes of Health (NIH) · NCT07743645
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 9–19 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- September 1, 2026
- Record last updated
- September 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to compare the effect of a brief family-based psychosocial intervention that addresses modifiable SSD risk factors on persistent and distressing psychotic-like experiences in children and young adults with a family history of SSD and high versus low baseline SSD-like brain patterns
Being studied: Psychosocial intervention group
Conditions: Schizophrenia Spectrum Disorders (SSD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Family history of SSD (defined as first-degree (e.g., a parent or a sibling), second-degree (e.g., an uncle or a grandparent), or other combinations of biological relatives in the family have or likely have a diagnosis of SSD or other closely related severe mental illnesses equivalent to at least 25% of genetic sharing) per medical record review and/or parent/legal guardian report and confirmed by a structured interview
- screening positive for two or more risk factors targeted by the intervention
- Participants and parent(s)/legal guardian(s) agree to participate
- psychiatrically stable and have no major changes in antidepressant, stimulant, or antipsychotic medication in the past 4 weeks.
Exclusion Criteria
- Current or past history of psychotic disorders or clinical high risk for psychosis (CHR-p) per study interview
- Current or past antipsychotic medication use to specifically treat a psychotic disorder
- major medical and neurological conditions
- moderate to severe intellectual disabilities or mild intellectual disabilities but expected to have difficulty completing the study assessments;
- current drug or alcohol use that impacts functioning and study engagement;
- Not able to give assent, permission, or consent.
- Not able to undergo MRI.
Recruiting US locations
The University of Texas Health Science Center at Houston
Houston, TX 77030
Site contact: Yizhou Ma, PhD · 713-486-2740 · Yizhou.Ma@uth.tmc.edu
Study contacts (from the official record)
- Yizhou Ma, PhD · 713-486-2740 · Yizhou.Ma@uth.tmc.edu
- Oluwabunmi Akindona, BA · 713-486-2740 · Oluwabunmi.Akindona@uth.tmc.edu
Similar studies in Texas
All mental health studies in Texas →- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Richardson, TX + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- DeSoto, TX + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersPhase 1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
- Location
- Houston, TX + 1 other US site
- Eligibility basics
- Ages 21–45
- RecruitingHealthy volunteersPhase 1
ACT for Individuals With MNCD and Their Care Partners
Texas Tech University
- Location
- Lubbock, TX
- Eligibility basics
- Ages 18+